Volume 66, Issue 2, Pages (August 2004)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Volume 68, Issue 5, Pages (November 2005)

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Volume 54, Issue 2, Pages (August 1998)

Long-term evolution of cardiomyopathy in dialysis patients

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Intensive hemodialysis—keeping the faith

Volume 70, Issue 3, Pages (August 2006)

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

End-stage renal disease in developing countries

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Volume 68, Issue 5, Pages (November 2005)

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

The risk of hospitalization and modality failure with home dialysis

Section 5: Dialysis Interventions for Treatment of AKI

Volume 77, Issue 1, Pages 6-8 (January 2010)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Need for better diabetes treatment for improved renal outcome

Volume 62, Issue 2, Pages (August 2002)

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Volume 62, Issue 2, Pages (August 2002)

Overcoming barriers that inhibit proper treatment of anemia

Volume 70, Pages S21-S25 (December 2006)

Anemia as a risk factor for chronic kidney disease

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Volume 74, Issue 3, Pages (August 2008)

Volume 68, Issue 1, Pages (July 2005)

Volume 63, Issue 2, Pages (February 2003)

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

Body weight is a fluctuating parameter in hemodialysis patients

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 70, Issue 12, Pages (December 2006)

Blood pressure targets in hemodialysis patients

Volume 76, Issue 6, Pages (September 2009)

Volume 61, Issue 6, Pages (June 2002)

Francesco Locatelli, Lucia Del Vecchio Kidney International

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Alternate-day dialysis may be needed for hemodialysis patients

Cardiovascular disease in pediatric chronic dialysis patients

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

Long-term evolution of cardiomyopathy in dialysis patients

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 65, Issue 5, Pages (May 2004)

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.

Volume 64, Issue 2, Pages (August 2003)

Current status of maintenance hemodialysis in Beijing, China

Does equal care give equal outcomes?

Volume 72, Issue 2, Pages (July 2007)

Pathophysiology of cardiovascular disease in hemodialysis patients

Is complement a target for therapy in renal disease?

Volume 68, Issue 2, Pages (August 2005)

Volume 62, Issue 6, Pages (December 2002)

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Jens Jordan, Johannes F. Mann, Friedrich C. Luft Kidney International

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Stephen Pastan, J. Michael Soucie, William M. McClellan

Volume 68, Issue 3, Pages (September 2005)

Letter from W. Lornoy; I. Becaus; J.M. Billiouw and L. Sierens

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 66, Issue 2, Pages 832-840 (August 2004) Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients Helga Frank, Karsten Heusser, Bernd Höffken, Peter Huber, Roland E. Schmieder, Hans P. Schobel Kidney International Volume 66, Issue 2, Pages 832-840 (August 2004) DOI: 10.1111/j.1523-1755.2004.00810.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Effect of correction of anemia with chronic recombinant human erythropoietin (rhEPO) substitution on sympathetic nerve activity (SNA). (A) Burst frequency. (B) Burst incidence. Abbreviations are: U1, renal anemia, no therapy of rhEPO; U2, renal anemia corrected under chronic substitution of rhEPO. Kidney International 2004 66, 832-840DOI: (10.1111/j.1523-1755.2004.00810.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Representative single microneurographic recording of the muscle sympathetic nerve activity (MSNA) of a dialysis patient before and after correction of renal anemia by recombinant human erythropoietin (rhEPO). Abbreviations are: U1, renal anemia, no therapy of rhEPO; U2, renal anemia corrected under chronic substitution of rhEPO. Kidney International 2004 66, 832-840DOI: (10.1111/j.1523-1755.2004.00810.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Effect of anemia correction by chronic recombinant human erythropoietin (rhEPO) treatment on left ventricular septal (IVS) and posterior wall thickness (LVPW). Abbreviations are: U1, renal anemia, no therapy of rh-Epo; U2, renal anemia corrected under chronic substitution of rh-Epo. Kidney International 2004 66, 832-840DOI: (10.1111/j.1523-1755.2004.00810.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Effect of anemia correction by chronic recombinant human erythropoietin (rhEPO) treatment on left ventricular mass index (LVMI). Abbreviations are: U1, renal anemia, no therapy of rhEPO; U2, renal anemia corrected under chronic substitution of rhEPO. Kidney International 2004 66, 832-840DOI: (10.1111/j.1523-1755.2004.00810.x) Copyright © 2004 International Society of Nephrology Terms and Conditions